This is a non-core endpoint: only basic statistics are computed.
Melanoma in situ of trunk
CD2_INSITU_MELANOMA_TRUNK_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D03
- Name in latin
- Melanoma in situ trunci
Similar endpoints
↥List of similar endpoints to
Melanoma in situ of trunk
based on the number of shared cases.
Similar with more cases:
- Melanoma in situ of trunk
- Melanoma in situ
- Melanoma in situ
- Malignant melanoma
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 433 | 161 | 272 |
| Unadjusted period prevalence (%) | 0.10 | 0.05 | 0.12 |
| Median age at first event (years) | 69.20 | 65.60 | 71.33 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 371
- Matched controls
- 3710
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.5
ICD-10 Finland
Melanoma in situ of trunk
+∞
323.0
371
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
181.6
293.7
290
71
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
35.6
108.9
143
64
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
82.4
76
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
15.2
78.1
140
142
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
856.2
73.8
70
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
296.5
73.2
72
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
23.3
73.2
108
64
L57.0
ICD-10 Finland
Actinic keratosis
12.1
64.9
129
156
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
19.4
64.2
101
70
PJA12
NOMESCO Finland
Sentinel node biopsy
653.8
58.3
56
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
51.2
48
*
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
20.9
50.3
76
45
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
196.3
50.2
51
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
49.0
46
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
45.8
43
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
6.5
41.8
125
269
130
Kela drug reimbursment
Malignant tumour
+∞
39.3
37
*
S18
ICPC
Laceration/cut
4.3
38.8
242
1120
TQW99
NOMESCO Finland
Other minor procedure on skin
15.2
37.3
63
49
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
37.1
35
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
37.1
35
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
22.7
36.5
53
27
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
34.9
33
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
33.9
32
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
19.5
31.5
48
28
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
41.3
27.6
34
9
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
27.4
26
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
27.4
26
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
19.3
26.4
40
23
ZZR00
NOMESCO Finland
Flap of skin
38.7
25.6
32
9
C43
ICD-10 Finland
Malignant melanoma of skin
+∞
25.3
24
*
115
Kela drug reimbursment
Breast cancer
+∞
25.3
24
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
23.2
22
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
29.5
22.6
30
11
ZXC50
NOMESCO Finland
Cryotherapy
18.6
22.2
34
20
S77
ICPC
Malignant neoplasm of skin
+∞
22.1
21
*
C43.51
ICD-10 Finland
Malignant melanoma of the trunk originating in lentigo maligna
+∞
22.1
21
*
116
Kela drug reimbursment
Prostate cancer
+∞
22.1
21
*
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
85.4
21.9
24
*
L82
ICD-10 Finland
Seborrhoeic keratosis
3.9
21.9
104
337
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
+∞
21.0
20
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
21.0
20
*
SPAT1153
SPAT
Removal of sutures
3.0
20.9
175
859
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
+∞
20.0
19
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
20.0
19
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
24.1
19.3
27
12
8720/2-C44.5
ICD-O-3
Melanoma in situ of skin of trunk
+∞
18.9
18
*
S82
ICPC
Naevus/mole
4.1
18.7
81
239
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
21.4
18.0
26
13
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
17.8
17
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
17.8
17
*
JN4BD
NOMESCO Finland
Extensive body CT
5.8
17.5
51
99
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
16.8
16
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
16.8
16
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
16.8
16
*
WF002
NOMESCO Finland
Radical radiotherapy
94.3
16.7
18
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
15.7
15
*
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
23.3
15.7
22
10
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
19.4
14.9
22
12
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
83.4
14.7
16
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
14.7
14
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
14.7
14
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
14.7
14
*
L02BG04
ATC
letrozole; oral
155.8
14.6
15
*
L02AE02
ATC
leuprorelin; implant, parenteral
31.4
14.0
18
6
ZQZ00
NOMESCO Finland
Treatment of several skin areas
55.5
13.9
16
*
H02AB02
ATC
dexamethasone; systemic
13.5
13.6
23
18
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
13.6
122
589
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
29.6
13.1
17
6
8743/3-C44.5
ICD-O-3
Low cumulative sun damage melanoma of skin of trunk
+∞
12.6
12
*
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
+∞
12.6
12
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
12.6
12
*
D06BB10
ATC
imiquimod; topical
6.1
12.3
33
58
ZXC20
NOMESCO Finland
Use of chemical agents
14.0
12.1
20
15
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
48.3
12.0
14
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.1
11.7
37
79
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
67.1
11.7
13
*
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
+∞
11.5
11
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
11.5
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
11.5
11
*
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
123.6
11.5
12
*
N02BE01
ATC
paracetamol; systemic, rectal
2.6
10.8
322
2646
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
61.8
10.7
12
*
D22
ICD-10 Finland
Melanocytic naevi
6.1
10.5
28
49
L02BB03
ATC
bicalutamide; oral
113.0
10.5
11
*
L02BA01
ATC
tamoxifen; oral
113.0
10.5
11
*
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
+∞
10.5
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
10.5
10
*
180
Kela drug reimbursment
Interferon alfa
+∞
10.5
10
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
10.5
10
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
10.5
10
*
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
+∞
10.5
10
*
XQ845
NOMESCO Finland
Dermatoscopy
12.5
10.5
18
15
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
11.1
10.4
19
18
S29
ICPC
Skin symptom/complaint other
2.5
9.9
83
378
HAB40
NOMESCO Finland
Wedge excision of mammary gland
56.5
9.7
11
*
XQ848
NOMESCO Finland
Dermatological photography
6.9
9.6
23
35
Y77
ICPC
Malignant neoplasm prostate
+∞
9.4
9
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
9.4
9
*
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
+∞
9.4
9
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
9.4
9
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
9.4
9
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
6.3
9.4
24
40
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
11.1
9.4
17
16
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
7.8
9.0
20
27
ZXC15
NOMESCO Finland
Use of photodynamic technique
24.7
9.0
12
5
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
24.7
9.0
12
5
S26
ICPC
Fear of cancer of skin
16.8
8.6
13
8
Z31.5
ICD-10 Finland
Genetic counselling
8.2
8.5
18
23
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.2
8.5
18
23
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
11.1
8.4
15
14
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
8.4
8
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
8.4
8
*
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
+∞
8.4
8
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
8.4
8
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
8.4
8
*
L01BC06
ATC
capecitabine; oral
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
8.0
97
524
A03FA01
ATC
metoclopramide; systemic, rectal
2.8
8.0
53
209
S21
ICPC
Skin texture symptom/complaint
2.7
7.9
56
231
XKD00
NOMESCO Finland
Uroflowmetry
2.3
7.9
84
426
JN4AD
NOMESCO Finland
Body CT examination
4.8
7.8
25
55
HA1AA
NOMESCO Finland
X-ray mammography
6.4
7.6
19
31
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.1
7.6
94
510
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
25.6
7.6
10
*
WX110
NOMESCO Finland
Local anesthesy
1.9
7.5
240
1842
WZC30
NOMESCO Finland
Teaching
2.7
7.5
50
199
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
81.6
7.4
8
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
81.6
7.4
8
*
A98
ICPC
Health maint/preventive medicine
3.1
7.4
351
3155
Z51.5
ICD-10 Finland
Palliative care
5.6
7.3
20
37
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
7.3
7
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
7.3
7
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
+∞
7.3
7
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
7.3
7
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
7.3
7
*
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
7.3
7
*
8742/2-C44.5
ICD-O-3
Lentigo maligna of skin of trunk
+∞
7.3
7
*
8742/3-C44.9
ICD-O-3
Lentigo maligna melanoma of skin, NOS
+∞
7.3
7
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.4
6.9
24
58
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
9.6
6.8
13
14
E0000UV
ATC
NA
1.9
6.8
137
889
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
17.1
6.8
10
6
J01DB01
ATC
cefalexin; oral
1.9
6.6
292
2438
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.2
6.6
68
339
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
6.5
69
348
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
71.0
6.4
7
*
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
71.0
6.4
7
*
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
14.6
6.4
10
7
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
C44
ICD-10 Finland
Other malignant neoplasms of skin
+∞
6.3
6
*
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
1509
Kela drug reimbursment
Dabrafenib (adjuvant treatment)
+∞
6.3
6
*
C43.30
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face without histology
+∞
6.3
6
*
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
6.3
6
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
6.3
6
*
3024
Kela drug reimbursment
Dabrafenib and trametinib (adjuvant treatment)
+∞
6.3
6
*
L01XE23
ATC
[U] dabrafenib; oral
+∞
6.3
6
*
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
27.2
6.2
8
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
27.2
6.2
8
*
R4110
NOMESCO Finland
Physiotherapy
1.9
6.2
93
543
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
12.8
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
65
205
3.55
17.51
4.2
1.5
4.6
4.2
ug/l
0.09
54
161
399
3277
3.77
13.95
20.7
12.4
74.7
75.2
ml/min/173m2
0.21
345
2660
251
1703
2.13
13.08
8.0
3.8
11.2
12.2
umol/l
0.98
233
1599
342
2653
2.38
12.29
9.9
5.2
80.5
76.1
u/l
0.62
320
2438
186
1148
2.09
12.25
4.9
2.1
2.3
2.4
mmol/l
0.16
159
939
404
3448
3.56
11.08
18.2
13.4
22.5
25.1
mg/l
0.96
336
2691
162
987
2.02
10.74
3.7
2.7
0.8
0.8
ug/l
0.11
115
673
254
1813
1.97
10.59
10.8
6.0
3.9
4.4
e9/l
2.63
211
1579
420
3707
5.43
10.29
13.7
9.1
25.4
25.5
u/l
0.02
401
3547
297
2266
1.99
9.86
4.5
4.3
5687.0
2194.7
e6/l
—
8
43
19
38
5.18
9.17
1.4
1.3
—
—
—
0
0
223
1594
1.82
8.56
5.9
5.3
1.2
1.2
mmol/l
0.56
191
1410
154
983
1.88
8.51
3.8
2.8
0.7
0.5
e6/l
0.33
114
731
238
1741
1.81
8.41
6.4
5.8
1.2
1.2
mmol/l
0.01
193
1498
414
3703
3.69
8.11
23.1
15.9
85.1
82.9
umol/l
0.57
414
3703
422
3832
4.99
7.85
28.3
20.0
134.5
136.4
g/l
1.80
416
3759
375
3225
2.22
7.52
5.5
4.4
1.9
2.4
mu/l
0.54
330
2898
187
1306
1.76
7.46
3.7
2.9
—
—
—
0
0
209
1510
1.74
7.37
6.0
3.7
35.4
35.3
g/l
0.06
195
1388
194
1374
1.75
7.34
2.2
2.2
80.3
78.1
nmol/l
0.53
172
1186
7
0
+∞
7.31
1.0
0.0
—
—
—
0
0
404
3602
2.82
7.23
5.7
5.5
2.6
2.6
mmol/l
0.13
357
3289
410
3694
3.07
6.97
22.7
16.7
4.0
4.0
mmol/l
4.28
399
3589
396
3513
2.49
6.87
5.2
4.9
4.5
4.5
mmol/l
0.26
354
3225
409
3685
2.98
6.86
22.3
16.6
139.9
139.8
mmol/l
0.32
399
3581
123
783
1.80
6.59
2.5
2.1
—
—
—
0
0
205
1505
1.69
6.59
4.3
3.7
—
—
—
0
0
383
3364
2.20
6.59
4.7
4.4
1.3
1.3
mmol/l
0.10
342
3039
392
3478
2.34
6.53
5.2
4.9
1.4
1.4
mmol/l
0.14
350
3167
98
584
1.88
6.49
3.4
2.8
0.9
2.1
e6/l
1.78
60
323
111
692
1.81
6.35
4.8
2.0
2.5
2.4
mmol/l
1.24
98
587
311
2580
1.73
6.06
4.4
3.6
15.1
15.0
pmol/l
0.40
265
2313
231
1780
1.64
5.94
6.3
4.1
8.5
2.1
ug/l
0.83
198
1587
216
1644
1.63
5.79
2.2
2.1
93.0
93.8
pmol/l
0.09
116
853
313
2633
1.68
5.45
4.6
4.0
12.4
12.4
mm/h
0.02
278
2391
143
994
1.65
5.43
3.1
2.6
5757.2
8245.0
umol/l
0.18
119
847
65
362
1.94
5.23
3.1
3.0
—
—
—
0
0
84
511
1.80
5.13
2.9
2.6
0.8
0.8
mmol/l
0.65
74
468
263
2136
1.59
5.12
4.8
4.3
6.6
6.8
mmol/l
1.02
255
1992
145
1026
1.62
5.07
2.6
2.7
35.7
35.2
u/l
0.03
138
971
390
3528
2.06
4.96
5.7
5.0
6.0
6.1
mmol/l
0.88
342
3182
378
3384
1.92
4.95
6.9
6.6
40.1
40.9
mmol/mol
1.08
340
3117
132
919
1.63
4.91
2.4
2.1
2.6
3.0
mg/l
0.82
104
782
47
245
2.03
4.56
1.8
2.2
12.2
15.1
nmol/l
1.67
40
212
321
2771
1.61
4.50
25.6
16.3
13.9
13.7
%
2.11
315
2711
53
291
1.94
4.45
2.9
1.6
64.8
67.3
g/l
1.50
48
261
8
274
0.28
4.42
3.5
6.3
23.8
24.5
mmol/l
—
8
257
47
248
2.00
4.41
4.1
2.7
1.2
1.2
mmol/l
0.27
37
215
24
99
2.51
4.04
4.3
1.3
40.7
54.0
mg/l
0.81
19
82
259
2162
1.49
3.97
2.8
3.0
40.2
48.2
u/l
1.93
233
1999
24
100
2.48
3.96
4.2
1.3
27.9
37.7
mg/l
1.04
19
84
93
624
1.62
3.93
3.2
2.6
1.2
1.0
e6/l
0.12
55
363
20
77
2.67
3.86
1.3
1.4
—
—
—
0
0
20
77
2.67
3.86
1.3
1.4
—
—
—
0
0
339
3012
1.58
3.73
22.0
15.0
38.8
39.7
%
0.81
236
1955
183
1439
1.47
3.71
4.6
4.0
21.5
24.4
%
1.80
103
708
177
1388
1.47
3.62
3.1
2.7
131.3
139.0
ug/l
0.22
154
1263
33
171
2.01
3.29
1.3
1.2
65.3
133.5
iu/ml
—
7
74
7
12
5.91
3.03
1.9
1.6
—
—
—
0
0
19
81
2.41
3.03
1.7
1.3
—
—
—
0
0
131
1010
1.43
2.80
1.6
1.5
20.4
20.4
nmol/l
0.01
102
862
16
66
2.48
2.74
1.4
1.4
—
—
—
0
0
154
1228
1.39
2.71
2.3
2.2
181.8
288.8
u/l
0.87
144
1136
208
1745
1.37
2.67
2.1
2.5
—
—
—
0
0
46
286
1.68
2.61
2.8
2.0
34.5
32.6
u/l
0.15
41
236
71
503
1.49
2.34
5.7
5.1
33.3
31.9
%
0.51
45
333
18
85
2.17
2.32
1.4
1.3
271.7
314.9
ug/g
0.51
12
51
27
149
1.87
2.30
2.8
1.3
6.8
7.6
g/l
1.38
20
107
27
149
1.87
2.30
2.8
1.3
—
—
—
0
0
27
149
1.87
2.30
2.8
1.3
3.6
3.9
g/l
0.56
20
102
103
790
1.40
2.23
1.7
1.8
1092.0
1183.8
nmol/l
0.43
62
604
5
9
5.60
2.22
1.8
2.2
—
—
—
0
0
194
1647
1.32
2.17
3.2
3.7
0.0
0.0
estimate
0.00
42
270
25
138
1.86
2.14
2.9
1.3
3.0
3.1
g/l
0.18
20
104
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
110
1.96
2.09
3.6
2.5
0.6
0.4
u/ml
0.87
12
60
6
15
4.04
2.04
1.7
1.3
153.2
192.3
u/l
—
6
15
101
786
1.37
1.99
4.4
4.0
113.5
337.7
ng/l
1.55
84
655
11
45
2.48
1.94
2.5
4.1
—
—
—
0
0
195
1676
1.30
1.93
3.2
3.6
0.0
0.0
estimate
0.00
42
268
43
286
1.56
1.91
3.6
4.2
113.6
92.6
ng/l
0.60
34
251
7
22
3.22
1.88
1.0
1.1
1.8
2.1
mmol/l
—
7
22
22
122
1.85
1.88
2.0
3.2
—
—
—
0
0
19
101
1.92
1.83
1.3
1.6
2658.0
17682.5
e6/l
—
9
76
12
53
2.30
1.82
1.6
1.6
281.3
272.6
mu/l
0.08
12
47
14
67
2.13
1.78
1.1
1.4
—
—
—
0
0
191
1653
1.28
1.74
4.5
5.0
0.0
0.0
estimate
0.00
43
269
5
13
3.88
1.72
2.2
1.4
2.6
4.4
nmol/l
—
5
13
7
25
2.83
1.65
1.0
1.3
14.6
15.3
ug/l
—
7
25
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
15
3.36
1.52
1.0
1.2
—
—
—
0
0
11
51
2.19
1.51
4.0
2.0
4.4
4.6
e9/l
0.17
11
51
50
363
1.43
1.49
2.6
2.4
7.7
7.3
umol/l
0.06
45
319
36
245
1.51
1.48
1.7
1.6
—
—
—
0
0
11
52
2.14
1.45
4.5
2.3
59.9
58.0
%
0.25
11
52
9
39
2.33
1.43
5.3
1.9
92.4
93.6
u/ml
—
9
33
61
465
1.36
1.38
5.4
5.2
1.0
1.0
mmol/l
0.08
55
418
5
17
2.96
1.36
1.2
1.2
—
—
—
0
0
6
24
2.52
1.31
1.0
1.5
—
—
—
0
0
5
18
2.80
1.29
1.6
1.2
5.9
7.4
mmol/l
—
5
18
72
577
1.30
1.18
32.9
29.8
1.2
1.3
inr
—
10
78
12
209
0.56
1.16
5.9
3.0
24.4
25.4
mmol/l
1.03
12
203
34
242
1.44
1.16
1.4
1.5
—
—
—
0
0
8
39
2.07
1.16
1.0
1.1
—
1.7
—
0
12
8
39
2.07
1.16
1.1
1.0
—
—
—
0
0
5
20
2.52
1.15
1.0
1.2
—
—
—
0
0
5
21
2.40
1.09
1.6
3.1
—
—
—
0
0
68
552
1.28
1.02
3.1
2.3
12.5
13.4
umol/l
0.39
63
500
12
68
1.79
1.01
1.2
1.6
—
—
—
0
0
7
35
2.02
1.00
2.9
1.9
—
—
—
0
0
7
36
1.96
0.97
1.1
1.1
—
—
—
0
0
8
146
0.54
0.94
1.3
1.6
—
—
—
0
0
25
177
1.44
0.90
3.4
3.6
24.1
24.5
mmol/l
0.20
25
160
114
997
1.19
0.87
1.6
1.7
1.3
1.3
mmol/l
0.43
87
819
12
72
1.69
0.86
1.7
2.1
205.0
222.8
pmol/l
0.41
12
67
22
154
1.45
0.85
2.6
2.3
657.2
638.6
ug/l
0.02
22
140
6
32
1.89
0.82
1.3
1.2
—
—
—
0
0
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
103
901
1.19
0.78
3.3
3.7
0.0
0.0
estimate
0.50
43
263
124
1103
1.17
0.77
3.2
2.1
58.6
57.6
u/l
0.12
109
1014
10
161
0.61
0.77
1.5
1.7
—
—
—
0
0
6
34
1.78
0.76
2.7
2.4
—
—
—
0
0
7
38
1.86
0.74
2.0
2.0
—
303.7
—
0
6
9
57
1.59
0.71
1.4
1.4
—
—
—
0
0
53
442
1.23
0.67
1.8
1.8
—
—
—
0
0
138
1252
1.15
0.66
3.3
3.0
2172.5
1484.5
ng/l
0.63
117
1067
53
443
1.22
0.65
1.8
1.7
—
—
—
0
0
8
131
0.60
0.64
1.0
1.0
—
—
—
0
0
71
613
1.19
0.63
1.7
1.7
—
—
—
0
0
0
20
0.00
0.60
0.0
2.5
—
—
—
0
0
6
35
1.72
0.58
1.0
1.2
—
—
—
0
0
12
172
0.69
0.57
5.9
4.3
24.8
25.1
mmol/l
0.18
12
161
14
98
1.44
0.57
1.2
1.2
—
—
—
0
0
141
1294
1.13
0.57
3.7
3.1
7.7
7.7
mmol/l
0.02
103
1083
27
214
1.28
0.54
2.1
1.8
—
—
—
0
0
13
91
1.44
0.53
3.2
4.1
47.2
26.0
mg/l
—
6
65
15
109
1.39
0.51
1.3
1.3
—
—
—
0
0
10
67
1.50
0.50
1.4
1.4
—
—
—
0
0
19
146
1.32
0.48
1.2
1.6
—
—
—
0
0
7
48
1.47
0.47
1.4
1.3
8.2
7.7
mmol/l
—
7
35
5
82
0.61
0.46
1.0
1.2
—
—
—
0
0
33
275
1.22
0.45
3.2
2.1
66.6
61.9
ml/min/173m2
0.33
20
107
17
131
1.31
0.42
1.9
1.5
—
123.3
—
0
6
12
87
1.39
0.42
1.8
1.7
—
—
—
0
0
8
57
1.41
0.42
1.5
2.3
—
—
—
0
0
5
33
1.52
0.41
1.2
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
231.9
—
0
8
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
5
34
1.48
0.40
1.2
1.3
67.8
67.7
pmol/l
—
5
34
80
726
1.13
0.40
2.9
1.7
1.7
1.3
mg/l
0.43
56
570
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
0
19
0.00
0.39
0.0
7.2
—
42.0
—
0
5
9
67
1.35
0.38
1.6
1.2
—
—
—
0
0
5
78
0.64
0.36
1.0
1.2
—
37.3
—
0
8
6
42
1.43
0.35
1.0
1.4
—
—
—
0
0
6
43
1.40
0.35
1.0
1.0
1.6
1.5
g/l
—
6
38
71
646
1.12
0.34
1.3
1.2
1.9
1.7
u/ml
0.05
23
173
6
45
1.34
0.34
1.2
1.4
—
—
—
0
0
11
83
1.33
0.32
2.4
2.4
7.7
7.9
kpa
0.19
11
75
33
289
1.15
0.29
1.2
1.4
—
—
—
0
0
141
1341
1.08
0.28
5.2
4.0
10.6
7.3
mg/mmol
0.48
86
868
19
224
0.84
0.26
1.7
1.5
—
—
—
0
0
5
75
0.66
0.26
1.0
1.4
—
—
—
0
0
92
863
1.08
0.26
1.5
1.8
392.6
8108520.6
pmol/l
0.50
67
703
44
402
1.11
0.22
1.6
1.4
—
—
—
0
0
23
201
1.15
0.21
2.2
2.5
1.0
1.1
%
0.52
23
201
5
42
1.19
0.21
1.6
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
24
271
0.88
0.20
3.2
2.9
123.9
129.8
g/l
0.51
24
266
16
137
1.17
0.19
1.1
1.4
—
—
—
0
0
11
132
0.83
0.18
1.7
1.3
—
—
—
0
0
5
68
0.73
0.17
1.6
1.1
363.2
20.2
u/l
—
5
59
43
460
0.93
0.15
7.8
6.3
0.1
1.4
mmol/l
1.71
34
351
8
96
0.83
0.14
2.3
1.7
—
—
—
0
0
8
97
0.82
0.14
1.0
1.2
—
—
—
0
0
8
97
0.82
0.14
1.0
1.2
—
—
—
0
0
24
263
0.91
0.13
4.1
3.7
5.2
5.2
kpa
0.04
24
243
52
548
0.94
0.12
1.2
1.3
3.3
11.8
u/ml
1.70
15
197
48
505
0.94
0.11
5.3
7.0
—
—
—
0
0
5
46
1.09
0.09
1.4
1.2
0.7
0.5
nmol/l
—
5
40
5
47
1.06
0.09
1.0
1.1
—
19.2
—
0
12
130
1272
1.03
0.09
3.4
3.9
—
—
—
0
0
60
580
1.04
0.07
1.2
1.3
35.1
38.0
iu/ml
0.06
18
178
21
222
0.94
0.05
1.3
1.4
—
50.4
—
0
11
13
121
1.08
0.03
6.5
1.8
—
—
—
0
0
35
339
1.04
0.03
1.7
1.8
2.0
1.7
%
0.61
30
285
153
1538
0.99
0.01
3.4
3.9
43.7
67.7
ng/l
0.50
112
1143
40
406
0.98
0.00
1.5
2.5
9.0
7.3
ug/l
0.26
33
347
0
8
0.00
0.00
0.0
1.5
—
100.5
—
0
8
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
78
0.90
0.00
1.4
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
6
62
0.97
0.00
1.0
1.3
—
—
—
0
0
6
67
0.89
0.00
1.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
6
68
0.88
0.00
1.2
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA_TRUNK_EXALLC – Melanoma in situ of trunk
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).